Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenomedullin reduces endothelial hyperpermeability.

Stefan Hippenstiel1, Martin Witzenrath, Bernd Schmeck

  • 1Charité, Department of Internal Medicine, Humboldt-University, Berlin, Germany. stefan.hippenstiel@charite.de

Circulation Research
|October 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease spectrum and medical complaints among migrants: a study from three outpatient clinics for asylum seekers in Berlin, Germany.

Frontiers in public health·2026
Same author

Bacterial extracellular vesicles modulate epithelial antiviral responses via macrophage-mediated immunomodulation.

Cell communication and signaling : CCS·2026
Same author

Harnessing generative AI for predicting and optimizing antimicrobial peptides against drug-resistant infections.

npj antimicrobials and resistance·2026
Same author

[Management of patients with chronic obstructive pulmonary disease in routine clinical practice].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Admission Eosinophil Count Is Associated With Hospital Resource Use in Community-Acquired Pneumonia: A Prospective Multicenter Study.

Chest·2026
Same author

Polygenic risk scores of chronic obstructive pulmonary disease (COPD) predict lung function decline and early COPD: results from COSYCONET.

American journal of respiratory and critical care medicine·2026

Adrenomedullin (ADM) reduces vascular leakage in sepsis and ARDS by stabilizing endothelial barrier function. This peptide increases cAMP levels, counteracting inflammatory mediator-induced hyperpermeability and improving outcomes.

Area of Science:

  • Vascular Biology
  • Cellular Physiology
  • Pharmacology

Background:

  • Endothelial hyperpermeability is a key feature of sepsis and ARDS.
  • Elevated adrenomedullin (ADM) levels are observed in systemic inflammatory responses.

Purpose of the Study:

  • To investigate the effect of ADM on endothelial permeability.
  • To explore the underlying mechanisms of ADM's action on endothelial cells.

Main Methods:

  • Cultured human umbilical vein endothelial cells (HUVECs) and porcine pulmonary artery endothelial cells were used.
  • Experiments involved exposure to inflammatory mediators (H2O2, thrombin, E. coli hemolysin) with and without ADM.
  • Measurements included cell permeability, cAMP levels, Ca2+ signaling, and cytoskeletal changes (myosin light chain phosphorylation, stress fibers).

Related Experiment Videos

  • Isolated perfused rabbit lungs were used to assess ADM's effect on edema formation.

    • Main Results:

    • ADM dose-dependently reduced endothelial hyperpermeability induced by various stimuli.
    • ADM inhibited edema formation in isolated perfused rabbit lungs.
    • ADM increased intracellular cAMP levels in endothelial cells and potentiated cAMP accumulation when phosphodiesterase inhibitors were present.
    • ADM did not affect cGMP or Ca2+ levels.
    • ADM reduced myosin light chain phosphorylation and stress fiber formation, indicating stabilization of the endothelial barrier.

    Conclusions:

    • ADM stabilizes endothelial barrier function through a cAMP-dependent mechanism.
    • ADM relaxes the microfilament system, reducing vascular leakage.
    • ADM represents a potential therapeutic agent for conditions characterized by increased vascular permeability, such as sepsis and ARDS.